A Novel Method to Identify Autoantibodies against Putative Target Proteins in Serum from beta-Thalassemia Major: A Pilot Study
Open Access
- 26 April 2020
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 8 (5), 97
- https://doi.org/10.3390/biomedicines8050097
Abstract
Abnormal immune reactivity in patients with beta-thalassemia (beta-thal) major can be associated with poor prognosis. Immunome protein-array analysis represents a powerful approach to identify novel biomarkers. The Sengenics Immunome Protein Array platform was used for high-throughput quantification of autoantibodies in 12 serum samples collected from nine beta-thal major patients and three non-thalassemia controls, which were run together with two pooled normal sera (Sengenics Internal QC samples). To obtain more accurate and reliable results, the evaluation of the biological relevance of the shortlisted biomarkers was analyzed using an Open Target Platform online database. Elevated autoantibodies directed against 23 autoantigens on the immunome array were identified and analyzed using a penetrance fold change-based bioinformatics method. Understanding the autoantibody profile of beta-thal major patients would help to further understand the pathogenesis of the disease. The identified autoantigens may serve as potential biomarkers for the prognosis of beta-thal major.This publication has 55 references indexed in Scilit:
- Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigensBMC Cancer, 2010
- The STRING database in 2011: functional interaction networks of proteins, globally integrated and scoredNucleic Acids Research, 2010
- Seromic profiling of ovarian and pancreatic cancerProceedings of the National Academy of Sciences of the United States of America, 2010
- Differential regulation of redox proteins and chaperones in HbEβ-thalassemia erythrocyte proteomeProteomics – Clinical Applications, 2009
- How do Regulatory T Cells Work?Scandinavian Journal of Immunology, 2009
- Proteomics, pathway array and signaling network-based medicine in cancerCell Division, 2009
- Blood Group Antibodies and Their Significance in Transfusion MedicineTransfusion Medicine Reviews, 2007
- A Double Heterozygote for (δβ)0-Thalassemia and Codons 41/42 (–TTCT) Behaves as a Homozygote for the Frameshift Mutation in a Chinese FamilyHemoglobin, 2007
- Hierarchical Grouping to Optimize an Objective FunctionJournal of the American Statistical Association, 1963
- Hierarchical Grouping to Optimize an Objective FunctionJournal of the American Statistical Association, 1963